| Variables |
Treatment group (with TXA and MBLPA) (n=44) |
Control group (without TXA or MBLPA) (n=43) |
P value | ||
|---|---|---|---|---|---|
|
Mean ± SD n(%) |
(Max-Min) |
Mean ± SD n(%) |
(Max-Min) | ||
| Months survivorship of previous implant |
67.7±63.6 | (7.6-253.0) | 58.4±52.6 | (2.7-242.8) | 0.480* |
| Surgical time (min) | 114.3±22.9 | (55.0-195.0) | 136.2±39.6 | (70.0-265.0) | 0.003* |
| Tourniquet time (min) | 107.9±15.4 | (70.0-140.0) | 107.2±20.3 | (60.0-150.0) | 0.863† |
| Revision diagnosis | |||||
| Aseptic loosening | 31 (70%) | 31 (72%) | 0.734‡ | ||
| Pain | 3 (7%) | 3 (7%) | |||
| Instability | 7 (16%) | 3 (7%) | |||
| Polyethylene wear | 2 (5%) | 3 (7%) | |||
| Prosthesis malposition | 1 (2%) | 2 (5%) | |||
| Fracture | 0 -- | 1 (2%) | |||
| Femoral defect type | |||||
| 1 | 7 (17%) | 10 (23%) | 0.720‡ | ||
| 2A | 24 (57%) | 19 (44%) | |||
| 2B | 9 (21%) | 11 (26%) | |||
| 3 | 2 (5%) | 3 (7%) | |||
| Tibial defect type | |||||
| 1 | 19 (48%) | 10 (23%) | 0.064‡ | ||
| 2A | 14 (35%) | 19 (44%) | |||
| 2B | 6 (15%) | 8 (19%) | |||
| 3 | 1 (3%) | 6 (14%) | |||
| Left side | 21 (50%) | 21 (53%) | 0.498‡ | ||